Understanding Neonatal Jaundice in Rwanda

Status Completed

Clinical Trial Summary

This study exploits the distribution of low-cost high-quality phototherapy devices (Brilliance by D-Rev) to public hospitals in Rwanda to assess whether the provision of improved technology improves health care for infant jaundice. Specifically, the investigators are interested in measuring whether the provision of an additional high-quality phototherapy device, a known effective treatment for jaundice, successfully translates into improved care of neonatal jaundice in Rwanda where the burden of jaundice is particularly high.

Clinical Trial Description

The Ministry of Health (MIH) in Rwanda has planned to provide Brilliance devices (phototherapy) to 46 public hospitals in Rwanda. The investigators have worked with MIH to have the delivery of these machines be staggered over three phases through random selection. The methodology relies on the staggered distribution of Brilliance devices and survey data collected prior and during delivery dates to evaluate the provision of low-cost high quality phototherapy machines, following the basic design of a staggered randomized controlled trial. Specifically, the investigators will survey all hospitals prior to the receipt of any Brilliance devices to provide a baseline description of the care received in these facilities. These surveys will collect information on the facility itself, including average infant jaundice caseloads and descriptions of recent cases. The investigators will then randomly select 15 hospitals to receive the Brilliance units. Three months after installation of Brilliance has occurred at these facilities (Group 1), another randomly selected subset of 16 facilities (Group 2) will receive their Brilliance machines. Three months after these installations have been completed, the remaining facilities (Group 3) will receive their Brilliance machines. During this period, there will be ongoing data collection from the hospitals, creating a panel dataset on the jaundice-related caseloads at these facilities. The data collected will be akin to collecting hospital records of patients diagnosed with jaundice, but no identifiable patient information will be collected. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03184948
Study type	Interventional
Source	University of California, Merced
Contact
Status	Completed
Phase	N/A
Start date	May 29, 2017
Completion date	June 1, 2018

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00735319` - Transcutaneous Bilirubinometers in the Community	N/A
Completed	`NCT00114543` - Trial of Aggressive Versus Conservative Phototherapy in Infants <1,000 Grams Birth Weight	Phase 3
Withdrawn	`NCT04021927` - Development of a Neonatal Jaundice Treatment Accelerator by Redirection of Unused Light During Phototherapy	N/A
Completed	`NCT01887327` - Stannsoporfin With Light Therapy for Newborn Babies With Jaundice	Phase 2
Completed	`NCT04632888` - The Effect of Telephone Support for Breastfeeding Follow-up on Infantile Colic and Maternal Breastfeeding Self-efficacy	N/A
Not yet recruiting	`NCT04527536` - Research of Diagnostic Value for BMJ Infants
Suspended	`NCT03741803` - Relationship Between Delayed Cord Clamping at Birth and Neonatal Bilirubin Levels in Parturients With a Prior Child Requiring Therapy for Neonatal Jaundice	N/A
Completed	`NCT05650463` - Evaluation of a Smartphone-based Screening Tool (Picterus Jaundice Pro) for Neonatal Jaundice in Dark Skin Newborns	N/A
Terminated	`NCT05623566` - Evaluation of a Smartphone Based Screening Tool for Neonatal Jaundice in Surabaya, Indonesia	N/A
Completed	`NCT02612727` - Filtered Sunlight Phototherapy to Treat Significant Jaundice: Safety and Efficacy in Neonates	N/A
Completed	`NCT01434810` - Treatment of Neonatal Jaundice With Filtered Sunlight Phototherapy: Safety and Efficacy in African Neonates	N/A
Completed	`NCT03942757` - BiLirubin Decrease Under Phototherapy Exposure in the Preterm Newborn in Incubator
Not yet recruiting	`NCT05806684` - Hyperbilirubinemia and Retinopathy of Prematurity in Preterm Infants: a Retrospective Study.
Completed	`NCT06372093` - Evaluation of Bilirubin Measurements in Newborns From Smartphone Digital Images in a Population in Botswana	N/A
Completed	`NCT03569254` - Effectiveness, Safety and Perceptions With the Use of One LED Blanket Device in the Ambulatory Treatment of Jaundice	N/A
Completed	`NCT03570775` - Effectiveness, Safety and Perceptions With the Use of One LED Sleeping Bag Device in the Treatment of Neonatal Jaundice	N/A
Completed	`NCT05625880` - Evaluation of Bilirubin Estimates in Newborns From Smartphone Digital Images in a Nepali Population	N/A
Completed	`NCT01169740` - Transcutaneous Measurement of Jaundice in the Newborn	N/A
Completed	`NCT05623553` - Evaluation of a Smartphone Based Diagnostic Tool to Assess Neonatal Jaundice in a Mexican Population	N/A
Completed	`NCT03007563` - Evaluation of a Smartphone Based Optical Diagnostic Tool for Neonatal Jaundice	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.